Skip to main content

Advertisement

Log in

Diagnostic value of 18F-FDG PET/CT for lymph node metastasis of esophageal squamous cell carcinoma

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

This study investigated the diagnostic accuracy of hybrid positron-emission tomography/computed tomography (PET/CT) for lymph node (LN) metastasis of esophageal cancer. We also investigated the correlation between the size of metastatic nests and the detection by PET/CT.

Methods

Two hundred and fifty-eight patients with esophageal squamous cell carcinoma who underwent esophagectomy with two- or three-field radical lymphadenectomy were analyzed retrospectively. We compared the diagnosis of preoperative PET/CT to the postoperative histopathological examination by each anatomical field (n = 1,231) in all 258 patients. The metastatic LNs resected from PET/CT positive fields were classified as belonging to the PET/CT-N-positive group (n = 229) and those from negative fields as belonging to the PET/CT-N-negative group (n = 352). The cross-sectional areas of metastatic nests were measured in each metastatic LN.

Results

Of the 1,231 fields, 275 (22 %) were positive for metastasis, including 581 LNs from 408 regional LN stations. The sensitivity and specificity of PET/CT examined by each anatomical field were 25.8 and 97.8 %, respectively. The median area of metastatic nests was 17.7 mm2 in the PET/CT-N-positive group, and 7.7 mm2 in the PET/CT-N-negative group (p < 0.001).

Conclusions

A significant correlation was suggested between the nest size and detection by PET/CT. Because of its low sensitivity, PET/CT alone is insufficient to determine the surgical procedures, especially when considering reduction surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Bollschweiler E, Baldus S, Schröder W, Prenzel K, Gutschow C, Schneider PM, et al. High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy. 2006;38:149–56.

    Article  CAS  PubMed  Google Scholar 

  2. Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg. 1994;220:364–72.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Altorki N, Kent M, Ferrara C, Port J. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg. 2002;236:177–83.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Kakeji Y, Yamamoto M, Ito S, Sugiyama M, Egashira A, Saeki H, et al. Lymph node metastasis from cancer of the esophagogastric junction, and determination of the appropriate nodal dissection. Surg Today. 2012;42(4):351–8.

    Article  PubMed  Google Scholar 

  5. Kato H, Nakajima M. The efficacy of FDG-PET for the management of esophageal cancer: review article. Ann Thorac Cardiovasc Surg. 2012;18:412–9.

    Article  PubMed  Google Scholar 

  6. Kato H, Kimura H, Nakajima M, Sakai M, Sano A, Tanaka N, et al. The additional value of integrated PET/CT over PET in initial lymph node staging of esophageal cancer. Oncol Rep. 2008;20:857–62.

    PubMed  Google Scholar 

  7. Yen T-J, Chung C-S, Wu Y-W, Yen R-F, Cheng M-F, Lee J-M, et al. Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma. Dis Esophagus. 2012;25:40–7.

    Article  PubMed  Google Scholar 

  8. Itoh K, Hosokawa M, Fujita M. <18F>FDG-PET/CT in esophageal cancer: comparison between PET and histopathological evaluation on metastasis to locoregional lymph node. (in Japanese). Jpn J Clin Radiol. 2008;53:501–7.

    Google Scholar 

  9. Han D, Yu J, Zhong X, Fu Z, Mu D, Zhang B, et al. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study. Dis Esophagus. 2012;25:416–26.

    Article  CAS  PubMed  Google Scholar 

  10. Tanabe S, Naomoto Y, Shirakawa Y, Fujiwara Y, Sakurama K, Noma K, et al. F-18 FDG PET/CT contributes to more accurate detection of lymph nodal metastasis from actively proliferating esophageal squamous cell carcinoma. Clin Nucl Med. 2011;36:854–9.

    Article  PubMed  Google Scholar 

  11. Wang F, Shen L-Y, Ma S-H, Li N, Yang Z, Chen K-N. Advantages of positron emission tomography-computed tomography imaging in esophageal squamous cell carcinoma. Dis Esophagus. 2012. doi:10.1111/j.1442-2050.2012.01407.x.

    Google Scholar 

  12. Yoon SK, Jung JI, Park MJ, Park HJ, Ahn MI, Park JG, et al. Multidetector CT assessment of lymph node size for nodal staging in patients with potentially operable squamous esophageal cancer and the 18F-FDG positron emission tomography CT correlation. J Korean Soc Radiol. 2010;62:235–43.

    Google Scholar 

  13. Okada M, Murakami T, Kumano S, Kuwabara M, Shimono T, Hosono M, et al. Integrated FDG-PET/CT compared with intravenous contrast-enhanced CT for evaluation of metastatic regional lymph nodes in patients with resectable early stage esophageal cancer. Ann Nucl Med. 2009;23:73–80.

    Article  PubMed  Google Scholar 

  14. Itoh K, Hosokawa M, et al. Companion to F-18FDG PET/CT (in Japanese). Tokyo: Medical Review; 2012.

    Google Scholar 

  15. The Japan Esophageal Society. Japanese Classification of Esophageal Cancer. April 2008 (The 10th ed., Revised Version) (in Japanese) Tokyo: Kanehara; 2008.

  16. Natsugoe S, Mueller J, Stein H, Feith M, Höfler H, Siewert J. Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma: frequency, associated tumor characteristics, and impact on prognosis. Cancer. 1998;83:858–66.

    Article  CAS  PubMed  Google Scholar 

  17. Greene FL, Page DL, Fleming ID, et al., editors. AJCC cancer staging manual. 6th ed. New York: Springer; 2002.

    Google Scholar 

  18. Sobin L, Wittekind C. International Union Against Cancer (UICC). TNM Classification of Malignant Tumors. 6th ed. New York: Wiley; 2002.

  19. Kato H, Kuwano H, Nakajima M, Miyazaki T, Yoshikawa M, Ojima H, et al. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer. 2002;94:921–8.

    Article  PubMed  Google Scholar 

  20. Pedersen P. Warburg, me and Hexokinase 2: multiple discoveries of key molecular events underlying one of cancers’ most common phenotypes, the ‘Warburg Effect’, i.e., elevated glycolysis in the presence of oxygen. J Bioenerg Biomembr. 2007;39:211–22.

    Article  CAS  PubMed  Google Scholar 

  21. Haley M, Konski A, Li T, Jonathan DC, Maurer A, Haluszka O, et al. Influence of diabetes on the interpretation of PET scans in patients with esophageal cancer. GCR. 2009;3:149–52.

    PubMed Central  PubMed  Google Scholar 

  22. Gorenberg M, Hallett W, O’Doherty MJ. Does diabetes affect [18F]FDG standardized uptake values in lung cancer? Eur J Nucl Med. 2002;29:1324–7.

    Article  CAS  Google Scholar 

  23. Torizuka T, Zasadny KR, Wahl RL. Diabetes decreases FDG accumulation in primary lung cancer. Clin Positron Imaging. 1999;2:281–7.

    Article  PubMed  Google Scholar 

  24. Lindholm P, Minn H, Leskinen-Kallio S, Bergman J, Ruotsalainen U, Joensuu H. Influence of the blood glucose concentration on FDG uptake in cancer—a PET study. J Nucl Med. 1993;34:1–6.

    CAS  PubMed  Google Scholar 

  25. Yasuda T, Higuchi I, Yano M, Miyata H, Yamasaki M, Takiguchi S, et al. The impact of 18F-fluorodeoxyglucose positron emission tomography positive lymph nodes on postoperative recurrence and survival in resectable thoracic esophageal squamous cell carcinoma. Ann Surg Oncol. 2012;19:652–60.

    Article  PubMed  Google Scholar 

  26. Strauss L. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med. 1996;23:1409–15.

    Article  CAS  PubMed  Google Scholar 

  27. Hosokawa M, Nishida Y, Koide T. Middle thoracic esophageal cancer (in Japasese). Shujutsu (Jpn Operation). 2007;61:271–7.

    Google Scholar 

  28. Mu DB, Wang SP, Yang WF, Fu Z, Chen XX, Sun XR, et al. Correlation between FDG PET/CT and the expression of glutI and ki-67 antigen in esophageal cancer (in Chinese). Zhonghua Zhong Liu Za Zhi. 2007;29:30–3.

    CAS  PubMed  Google Scholar 

Download references

Conflict of interest

We declare no potential conflicts of interest in association with this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hiroyuki Yamada.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yamada, H., Hosokawa, M., Itoh, K. et al. Diagnostic value of 18F-FDG PET/CT for lymph node metastasis of esophageal squamous cell carcinoma. Surg Today 44, 1258–1265 (2014). https://doi.org/10.1007/s00595-013-0725-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-013-0725-z

Keywords

Navigation